Catalyst Wire Dossier Catalyst Wire Dossier

Batiraxcept

AVB-S6-500 · Aravive, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Batiraxcept, covering 2023-10-30 to 2023-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer [Phase 3]

See pricing